Synthetic Biologics (SYN) Reports FY18 Loss of $4.06

Synthetic Biologics (NYSE: SYN) reported FY18 EPS of ($4.06), versus ($6.23) reported last year.

Cash and cash equivalents on December 31, 2018 were $28.9 million, an increase of $11.8 million from December 31, 2017.

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
• Hershey (HSY) PT Lowered to $206; RBC Capital: 'Struggling to See a Near Term Positive Inflection'